Rothschild & Co analyst Simon Clinch upgraded CME Group to Buy, raising the price target to $323 from $316. The rating was increased from Neutral.

Rating and Target Changes

The following table details the revised ratings and price targets for CME Group:

CME Group and Morningstar have entered into a multi-year licensing agreement to launch derivatives products based on key Morningstar equity index benchmarks. The exclusive agreement will enable CME Group to offer derivatives on the Morningstar Market Indexes, which underpin over $3 trillion in linked assets. This move aims to provide clients with risk management tools based on indexes that are currently rebranding from CRSP.

The agreement covers several benchmarks, including the Morningstar US Total Market, Large Cap, Large Cap Value, Large Cap Growth, Mid Cap, and Small Cap Indexes. Tim McCourt, CME Group Senior Managing Director and Global Head of Equities, FX and Alternative Products, stated that the partnership is expected to unlock precise risk management tools for the global investment community.

Morningstar Indexes President Amelia Furr highlighted that the collaboration will bring derivative products to the Morningstar Market Indexes for the first time. Furr noted that the acquisition of CRSP earlier this year has positioned Morningstar as a leading provider of U.S. equity benchmarks. The new relationship with CME Group is expected to accelerate growth and introduce the indexes to a new segment of the global investment marketplace.

Key Indexes Covered

The licensing agreement encompasses a range of equity benchmarks designed to provide comprehensive exposure to the U.S. market.

Strategic Implications

The integration of Morningstar's data-driven benchmark ecosystem with CME Group's liquid equity derivatives marketplace is anticipated to offer clients an optimized framework. This framework is designed to help investors navigate market volatility and capture new opportunities. The agreement marks a significant expansion in the availability of derivatives linked to Morningstar's equity indexes.